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Medicare Part D: The Intent 
• Plans offered through private insurance 
companies 
• Competition would decrease drug prices 
• Each company can: 
• Offer up to three plans per region 
• Determine formulary and restrictions* 
• Decide on cost-sharing structure* 
• All beneficiaries can enroll in a different plan 
during the annual open enrollment period  
• 2006-2010: November 15th - December 31st 
• 2011- Currently: October 15th - December 7th  
 
Medicare Part D: The Challenge 
• Too much choice? 
• Beneficiaries must choose from a myriad of insurance plans 
in order to receive prescription drug coverage.  
 
• Confusion? 
• Each year beneficiaries are confronted with: 
• Plan cancellations 
• New plan offerings 
• Benchmark plan changes 
• Changes in existing plan formularies 
• Changes in cost-sharing structure 
 
• Opportunity Cost (OC)? 







• To longitudinally examine the relationship 
between stand-alone prescription drug plan 
(PDP) costs, subsidy status, and the number of 
PDPs and benchmark plans offered in California 
from 2008-2012. 
 
47 community outreach events were 
held throughout Central and 
Northern California cities during 
2008-2012 Medicare Part D annual 
election periods 
Methods 
1,578 beneficiaries were assisted,  
983 (62.2%) of whom had a PDP 
Recorded from 
Medicare website: 
• Subsidy status 
• Cost data for the 
beneficiary’s current 
plan  
• Lowest cost plan for 
the upcoming year 
Intervention 
• Trained pharmacy students provided 
interventional assistance to each beneficiary: 
• Medicare Part D Plan Assistance 
• Low-Income Subsidy screening 
• Comprehensive Medication Therapy Management 
• Prescriber/Pharmacy follow-up 
Data Collection and Analysis 
• Standardized data collection tool was used to 
collect the following: 
• Demographic Information 
• Subsidy status, benchmark plan offerings and plan cost 
data (www.medicare.gov)  
 
• The potential opportunity cost (OC) of a 
beneficiary remaining in their current PDP as 
opposed to the lowest cost PDP was calculated: 
• OC = [EAC ($) of Current Plan in the upcoming year – 




Demographic Characteristics of Beneficiary 
Attendees with a PDP: 2007-2011  















Total (%) or  
Weighted 
Mean + SD 
 
Female, No . (%) 32 (70) 131 (58) 84 (48) 148 (56) 209 (64) 604 (58) 
Age, Mean + SD 76.1 + 9.6 75.5 + 8.4 75.5 + 10.0 74.6 + 9.7 75.9 + 9.0 75.4 + 9.9 
White, No. (%)  29 (63) 95 (42) 84 (48) 159 (61) 191 (58) 553 (54.0) 
Preferred Language = 
English, No. (%)  39 (88) 111 (49) 106 (61) 195 (74) 241 (72) 692 (66) 
Married, No. (%) 25 (56) 146 (65) 97 (56) 160 (61) 188 (58) 616 (60) 
Education > High 
School, No. (%) 26 (58) 89 (41) 85 (49) 154 (60) 209 (66) 563 (56) 
No Subsidy, No. (%)  39 (85) 101 (45) 83 (48) 174 (65) 189 (57) 586 (56) 
Prescriptions,         
Mean + SD 5.0 + 3.4 5.4 + 3.3 5.2 + 3.4 5.2 + 3.4 5.3 + 3.8 5.3 + 3.9 
Potential OC of Remaining in the                 















(%) or Weighted 
Mean + SD 
$0, No. (%) 1 (2) 32 (14) 41 (23) 62 (23) 67 (21) 203 (20) 
25th percentile $148  $75  $3  $7  $11  -  
50th percentile $329  $327  $151  $186.50  $226  - 











$606 + $2180  
75th percentile $623  $891  $467  $489  $733  - 
Maximum $2,175  $4,512  $20,824  $4,804  $18,709  - 
Annual Mean Potential OC as a Function of 




































































Total (%) or 
Weighted 
Mean + SD 
$0, No. (%) 1 (3) 6 (6) 6 (7) 24 (14) 28 (15) 65 (11) 
25th percentile $156 $197 $171 $75.25 $138 - 
50th percentile $328 $488 $322 $268.50 $341 - 











$640 + $1929 
75th percentile $598 $878 $603 $474 $783 - 
Maximum $1,167 $4,512 $20,824 $4,697 $14,174 - 
Annual Mean Potential OC as a Function of 
PDP Offerings for Non-Subsidy Recipients  
 
Annual Mean Potential OC as a Function 































































Annual Mean Potential OC as a Function 
of PDP Offerings for Subsidy Recipients 
Potential 
Opportunity 














Mean + SD 
$0, No. (%) 0 (0) 26 (21) 35 (39) 38 (40) 39 (29) 138 (31) 
25th percentile $81  $26  $0  $0  $0  - 
50th percentile $1,229  $169  $8  $42.50  $74  - 











$573 + $1732 
75th percentile $1,806  $936  $160  $883  $317  - 
Maximum $2,175  $4,182  $3,185  $4,804  $18,709  - 
Conclusion 
• Despite a reduction in plan (PDP and benchmark) 
offerings between 2007 and 2011, most 
beneficiaries were still faced with significant 
avoidable out-of-pocket costs by remaining in the 
same plan. 
 
• Annual Part D plan reexamination is essential to 
ensure that ALL beneficiaries optimize their 
prescription medication insurance coverage and 
minimize their out-of-pocket costs. 
 
